methotrexate has been researched along with Movement Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, AP; Mao, RR; Xu, L; Yang, YX; Yu, CL; Zhou, H | 1 |
Dixit, A; Gupta, M; Madkaikar, M; Patil, V | 1 |
Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
Batchelor, TT; Buchbinder, BR; Harris, NL | 1 |
Ikuta, H; Mitsufuji, N; Sawada, T; Yoshioka, H | 1 |
Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK | 1 |
Aspnes, GT; Kalavsky, SM; Kammerer, BL; Klatskin, EH; McIntosh, S; O'Brien, RT; Pearson, HA; Snead, C | 1 |
7 other study(ies) available for methotrexate and Movement Disorders
Article | Year |
---|---|
Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Infarction; Brain Ischemia; Disease Models, Animal; Etoposide; Exercise Test; Ifosfamide; Intracranial Thrombosis; Lasers; Locomotion; Male; Methotrexate; Mice; Mice, Inbred Strains; Movement Disorders; Rotarod Performance Test; Wakefulness | 2015 |
Predominant Neurologic Manifestations Seen in a Patient With a Biallelic Perforin1 Mutation (PRF1; p.R225W).
Topics: Adult; Brain Stem; Child, Preschool; Codon; Cyclosporine; Demyelinating Diseases; Dexamethasone; Exons; Female; Ferritins; Frontal Lobe; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Muscle Weakness; Mutation, Missense; Perforin; Recurrence; Respiratory Tract Infections | 2017 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2005. A 35-year-old woman with difficulty walking, headache, and nausea.
Topics: Adult; Antimetabolites, Antineoplastic; Biopsy; Brain Neoplasms; Corpus Callosum; Diagnosis, Differential; Female; Headache; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Movement Disorders; Nausea; Neoplasm Recurrence, Local; Parietal Lobe; Stereotaxic Techniques; Tomography, X-Ray Computed | 2005 |
Lenńox-Gastaut syndrome associated with leukoencephalopathy.
Topics: Adolescent; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Calcinosis; Cranial Irradiation; Cytarabine; Dementia; Doxorubicin; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Humans; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Movement Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Radiation Injuries; Syndrome; Vincristine | 1996 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant; Injections, Spinal; Leucovorin; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Movement Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Psychomotor Performance; Remission Induction; Risk; Socioeconomic Factors; Survivors; Vincristine | 1999 |
Chronic neurologic disturbance in childhood leukemia.
Topics: Adolescent; Antineoplastic Agents; Child; Cyclophosphamide; Cytarabine; Folic Acid; Humans; Learning Disabilities; Leukemia; Leukemia, Lymphoid; Methotrexate; Movement Disorders; Nervous System Diseases; Prospective Studies; Radiotherapy; Seizures; Time Factors | 1976 |